Lucas Ward
Stock Analyst
(n/a)
# 4,642
Out of 4,650 analysts
12
Total ratings
n/a
Success rate
n/a
Average return
Main Sectors:
Stocks Rated by Lucas Ward
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
HSCS Heart Test Laboratories | Reiterates: Buy | $15 | $3.06 | +390.20% | 1 | Sep 23, 2024 | |
CYTH Cyclo Therapeutics | Maintains: Buy | $2.6 → $0.95 | $0.73 | +31.03% | 2 | Aug 26, 2024 | |
LIQT LiqTech International | Reiterates: Buy | $5.15 | $1.78 | +189.33% | 2 | Aug 26, 2024 | |
ACON Aclarion | Maintains: Buy | $1.6 → $1.5 | $0.19 | +673.20% | 2 | Aug 26, 2024 | |
VVOS Vivos Therapeutics | Maintains: Buy | $6.4 → $6.6 | $2.90 | +127.59% | 1 | Aug 20, 2024 | |
VMAR Vision Marine Technologies | Maintains: Buy | $338 → $270 | $3.82 | +6,968.06% | 2 | Jul 29, 2024 | |
SXTP 60 Degrees Pharmaceuticals | Initiates: Buy | $29 | $0.78 | +3,587.11% | 1 | Oct 2, 2023 | |
PIXY ShiftPixy | Initiates: Buy | $2,160 | $6.53 | +32,978.10% | 1 | Mar 6, 2023 |
Heart Test Laboratories
Sep 23, 2024
Reiterates: Buy
Price Target: $15
Current: $3.06
Upside: +390.20%
Cyclo Therapeutics
Aug 26, 2024
Maintains: Buy
Price Target: $2.6 → $0.95
Current: $0.73
Upside: +31.03%
LiqTech International
Aug 26, 2024
Reiterates: Buy
Price Target: $5.15
Current: $1.78
Upside: +189.33%
Aclarion
Aug 26, 2024
Maintains: Buy
Price Target: $1.6 → $1.5
Current: $0.19
Upside: +673.20%
Vivos Therapeutics
Aug 20, 2024
Maintains: Buy
Price Target: $6.4 → $6.6
Current: $2.90
Upside: +127.59%
Vision Marine Technologies
Jul 29, 2024
Maintains: Buy
Price Target: $338 → $270
Current: $3.82
Upside: +6,968.06%
60 Degrees Pharmaceuticals
Oct 2, 2023
Initiates: Buy
Price Target: $29
Current: $0.78
Upside: +3,587.11%
ShiftPixy
Mar 6, 2023
Initiates: Buy
Price Target: $2,160
Current: $6.53
Upside: +32,978.10%